Smith Salley Wealth Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-986
| Closed | -$32K | – | 264 |
|
|
2021
Q3 | $32K | Sell |
986
-7,440
| -88% | -$241K | ﹤0.01% | 251 |
|
|
2021
Q2 | $361K | Buy |
8,426
+7,440
| +755% | +$319K | 0.03% | 204 |
|
|
2021
Q1 | $48K | Buy |
986
+721
| +272% | +$35.1K | ﹤0.01% | 230 |
|
|
2020
Q4 | $9K | Hold |
265
| – | – | ﹤0.01% | 213 |
|
|
2020
Q3 | $11K | Hold |
265
| – | – | ﹤0.01% | 189 |
|
|
2020
Q2 | $12K | Buy |
+265
| New | +$12K | ﹤0.01% | 190 |
|